Petlife Pharmaceuticals, Inc.
PTLF · OTC
8/31/2017 | 8/31/2016 | 8/31/2015 | 8/31/2014 | |
|---|---|---|---|---|
| Market Cap | $430 | $342 | $86 | $2,607 |
| - Cash | $54 | $1 | $0 | $7 |
| + Debt | $717 | $153 | $0 | $0 |
| Enterprise Value | $1,093 | $494 | $86 | $2,601 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$221 | -$60 |
| % Margin | – | – | – | – |
| EBITDA | -$22,873 | -$3,687 | -$1,932 | -$1,512 |
| % Margin | – | – | – | – |
| Net Income | -$23,257 | -$3,687 | -$1,932 | -$1,512 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.33 | -0.4 | -0.17 | -0.2 |
| % Growth | 17.5% | -135.3% | 15% | – |
| Operating Cash Flow | -$319 | -$152 | -$22 | -$267 |
| Capital Expenditures | $0 | $0 | -$1 | $0 |
| Free Cash Flow | -$319 | -$152 | -$23 | -$267 |